|

Relapsed glioblastoma Clinical Trials

1 actively recruiting trial

Top Sponsors

  • University Hospital, Bordeaux1

Indications

  • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype1
  • Relapsed Cancer1
  • Cancer1

Other1 trial

Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.